Drug
Enoxaparin clinical trials
Includes 36 studies of Enoxaparin sodium.
How each study uses Enoxaparin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Enoxaparin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 Mar 1993 · LOVENOX (PRESERVATIVE FREE) · NDA 020164 (FDA, Drugs@FDA; as enoxaparin sodium)
- European Union
- 14 Sept 2016 · Thorinane · EMEA/H/C/003795 (EMA; as enoxaparin sodium; a biosimilar; now lapsed)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
185 studies that test it; most in 2020 (23); 1 more planned to start later
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 3 |
| 2001 | 1 |
| 2002 | 5 |
| 2003 | 3 |
| 2004 | 7 |
| 2005 | 1 |
| 2006 | 10 |
| 2007 | 8 |
| 2008 | 10 |
| 2009 | 12 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 12 |
| 2013 | 8 |
| 2014 | 12 |
| 2015 | 10 |
| 2016 | 9 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 23 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 9 |
| 2025 | 1 |
| 2026 | 7 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 34 · Other 153
Sanofi (13) · University of Utah (6) · Les Laboratoires des Médicaments Stériles (4) · Assistance Publique - Hôpitaux de Paris (3) · Massachusetts General Hospital (3) · Beth Israel Deaconess Medical Center (2) · University Hospital, Geneva (2) · Tampere University Hospital (2)
Often tested with
Tested in the same studies.
Heparin (11) · Rivaroxaban (11) · Aspirin (9) · Dalteparin (7) · Tinzaparin (6) · Apixaban (5) · Fondaparinux (5) · Warfarin (4)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 3 phase 3 studies under way
Enoxaparin is the comparator. A study of two new drugs counts under both.
- 1Dabigatran · Institute of Liver and Biliary Sciences, India
- 1Cenvacibart · Regeneron Pharmaceuticals · next primary completion Feb 2027
- 1Ethanol · University Hospital, Clermont-Ferrand · next primary completion Dec 2026
Reaching primary completion within a year · 9, 1 in phase 3
Studies that test Enoxaparin, phase 3 first.
- Apr 2027Catheter-Related Early Thromboprophylaxis With Enoxaparin StudiesPhase 2/3 · Yale University
- Dec 2026STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated ThrombosisPhase 4 · Tzu-Fei Wang
- Dec 2026Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S DeficiencyPhase 2 · Peking University People's Hospital
- Dec 2026Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)Phase 4 · University of California, Irvine
- Jan 2027Effect of LMWH on Neonatal Outcomes in Isolated OligohydramniosPhase 4 · PAEC General Hospital, Islamabad
- Jan 2027Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO SupportPhase 4 · Medical University of Vienna
- Mar 2027Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot ProjectPhase 2 · Endeavor Health
- Jun 2027THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)Phase 4 · Imperial College London
- Jul 2027Prophylactic Anticoagulation for Central Venous Line Insertion in Critically Ill ChildrenNot applicable · Menoufia University
Studies
Open first, then newest update. How each study uses Enoxaparin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 187
- Effect of LMWH on Neonatal Outcomes in Isolated OligohydramniosRecruitingPhase 4PAEC General Hospital, IslamabadNCT07907731Written as Enoxaparin (LMWH)
- Efficacy of Progesterone and Low Molecular Weight Heparin in Recurrent Pregnancy LossNot yet recruitingPhase 3General University Hospital, PragueNCT07796737Written as Enoxaparin (Clexane)
- LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyEnrolling by invitationPhase 4Massachusetts General HospitalNCT03244020Written as Enoxaparin 40Mg/0.4mL Prefilled Syringe
- Prophylactic Anticoagulation for Central Venous Line Insertion in Critically Ill ChildrenRecruitingNot applicableMenoufia UniversityNCT07710482Written as Enoxaparin
- A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).RecruitingPhase 2European Foundation for Study of Chronic Liver FailureNCT05895136Written as Enoxaparin
- Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot ProjectRecruitingPhase 2Endeavor HealthNCT06004674Written as Lovenox 40mg
- Thromboprophylaxis in Lower Limb ImmobilisationRecruitingPhase 3Queen Mary University of LondonNCT06370273Written as Enoxaparin Injectable Solution
- Catheter-Related Early Thromboprophylaxis With Enoxaparin StudiesRecruitingPhase 2/3Yale UniversityNCT04924322Written as Enoxaparin
- THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingPhase 4Imperial College LondonNCT05735639Written as Enoxaparin Sodium
- Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).Not yet recruitingPhase 3Johns Hopkins All Children's HospitalNCT06628778Written as Enoxaparin
- Study to Determine the Comparative Pharmacodynamics of Enoxaparin Sodium Biosimilar With That From ClexaneNot yet recruitingPhase 1Egyptian International Pharmaceutical Industries CoNCT07517289Written as Enoxaparin 40 Mg/0.4 mL Injectable Solution
- Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth RestrictionNot yet recruitingNot applicableMuhammad Aamir LatifNCT07462182Written as Enoxaparin
- STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated ThrombosisRecruitingPhase 4Tzu-Fei WangNCT05255003Written as Enoxaparin
- Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT PreventionRecruitingPhase 4Mayo Hospital LahoreNCT07243080Written as Enoxaparin 40 mg SC
- Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)RecruitingPhase 4University of California, IrvineNCT04861103Written as Lovenox
- LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)Enrolling by invitationPhase 3Centro Hospitalar de Lisboa CentralNCT04762992Written as subcutaneous Enoxaparin
- Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic SurgeryRecruitingPhase 4Helsinki University Central HospitalNCT05245877Written as enoxaparin/tinzaparin/dalteparin
- Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO SupportRecruitingPhase 4Medical University of ViennaNCT06442267Written as Enoxaparin Injectable Solution
- Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S DeficiencyNot yet recruitingPhase 2Peking University People's HospitalNCT06531525Written as Enoxaparin
- Low-Dose Enoxaparin in PsoriasisNot yet recruitingNot applicableZagazig UniversityNCT06416566Written as Subcutaneous Enoxaparin
See all 187 studies that test Enoxaparin →
Given beside what is tested · 22 — Enoxaparin is usual care or a partner of the new treatment
- Randomized Assessor-Masked Trial of Moderate Graduated Compression Stockings for Popliteal Vein Dilation During Long-Haul Economy-Class Air Travel After Aesthetic SurgeryRecruitingNot applicableResearch IncNCT07810192Written as Enoxaparine
- D2 Versus D3 Dissection in Laparoscopic Right HemicolectomyNot yet recruitingNot applicableGeneral Committee of Teaching Hospitals and Institutes, EgyptNCT06049758Written as Enoxaparin 40 Mg/0.4 mL Injectable Solution
- Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of HeparinCompletedPhase 1VarmX B.V.NCT06517563Written as Enoxaparin
- Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)TerminatedPhase 4Weill Medical College of Cornell UniversityNCT04406389Written as Enoxaparin sodium
- A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet AlfaCompletedPhase 1Portola PharmaceuticalsNCT03083704Written as Enoxaparin sodium
- Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary EmbolismCompletedPhase 1/2Daiichi SankyoNCT02923115Written as Enoxaparin
- Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)CompletedPhase 2Portola PharmaceuticalsNCT03551730Written as PRT064445/Enoxaparin
- Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 PatientsCompletedPhase 3RAAS Nutritionals, LLCNCT05417997Written as Enoxaparin
- Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary EmbolismTerminatedPhase 4Cedars-Sinai Medical CenterNCT04558125Written as Enoxaparin
- Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet TransplantationCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00789308Written as Klexane® (Enoxaparinsodium)
- A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With HemodialysisCompletedPhase 1/2Bristol-Myers SquibbNCT03000673Written as Enoxaparin
- Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19Status unknownPhase 4Clinica San Camilo, ArgentinaNCT04530578Written as Enoxaparin
- PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic CancerCompletedPhase 2Halozyme TherapeuticsNCT01839487Written as Enoxaparin
- Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®CompletedPhase 1/2Indonesia UniversityNCT04402762Written as Enoxaparin Prefilled Syringe [Lovenox]
- PK and PD of Single, Escalating Doses of PER977 Following EnoxaparinCompletedPhase 1/2Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.NCT02206100Written as enoxaparin
- Warfarin Initiation in Mechanical Mitral Valve Replacement PatientsCompletedPhase 4Sarah Sabry HashemNCT04235569Written as Enoxaparin Sodium 100 MG/ML Prefilled Syringe
- Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC SubtypeTerminatedPhase 1/2M.D. Anderson Cancer CenterNCT02589145Written as Enoxaparin
- Aspirin and Enoxaparin for VTE in TraumaTerminatedPhase 4University of MiamiNCT02396732Written as Enoxaparin
- STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial InfarctionCompletedPhase 3Boehringer IngelheimNCT00623623Written as enoxaparin
- Topical Tranexamic Acid and Floseal® in Total Knee ArthroplastyStatus unknownPhase 4Chang Gung Memorial HospitalNCT02865174Written as Enoxaparin
Showing 20 of 22.
As the comparator · 92 — what is tested is compared with Enoxaparin
- REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in AdultsRecruitingPhase 3Regeneron PharmaceuticalsNCT07015905Written as Enoxaparin
- Comparison of DOACs and LMWH for Thromboprophylaxis After Total Knee ArthroplastyRecruitingNot applicableMilitary Hospital of TunisNCT07869615Written as Enoxaparin (LMWH)
- Rivaroxaban vs Enoxaparin After Cesarean Section: Laboratory Thromboprophylaxis OutcomesRecruitingNot applicableWolfson Medical CenterNCT07820670Written as Enoxaparin 40 mg
- Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord InjuryRecruitingNot applicableLoewenstein HospitalNCT05484557Written as Enoxaparin Sodium
- Apixaban Versus Enoxaparin for Postpartum Venous Thromboembolism ProphylaxisNot yet recruitingNot applicableRon Beloosesky MDNCT07716332Written as Enoxaparin
- The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.Not yet recruitingNot applicableUniversity College DublinNCT07559643Written as enoxaparin
- A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKARecruitingPhase 2Sirius Therapeutics Co., Ltd.NCT07140523Written as enoxaparin
- Apixaban or Enoxaparin After Head and Neck Cancer SurgeryRecruitingPhase 4Kiranya ArnoldNCT07189897Written as Enoxaparin
- Edoxaban Steady-State PK/PD in Adults With Nephrotic SyndromeNot yet recruitingNot applicablePeking University People's HospitalNCT07116239Written as Enoxaparin 40 mg
- Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee ArthroplastyRecruitingPhase 2Livzon Pharmaceutical Group Inc.NCT06963320Written as Enoxaparin Sodium Injection
- Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric SurgeryRecruitingNot applicableAlexandria UniversityNCT06689241Written as Enoxaparin
- Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With CirrhosisNot yet recruitingPhase 2/3Institute of Liver and Biliary Sciences, IndiaNCT06818279Written as Enoxaparin
- Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis PatientsRecruitingPhase 3University Hospital, Clermont-FerrandNCT03083184Written as enoxaparin
- A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee ArthroplastyCompletedPhase 3Beijing Suncadia Pharmaceuticals Co., LtdNCT06825416Written as Enoxaparin sodium injection
- Rivaroxaban in Pediatric Patients With DVTCompletedPhase 4Ain Shams UniversityNCT07618988Written as Enoxaparin, Heparin
- A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult ParticipantsCompletedPhase 2Regeneron PharmaceuticalsNCT06454630Written as Enoxaparin
- Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to EnoxaparinCompletedPhase 3Avexima Diol LLCNCT07124819Written as Sodium enoxaparin
- Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee ArthroplastyTerminatedPhase 2Shanghai Hengrui Pharmaceutical Co., Ltd.NCT05203705Written as Enoxaparin
- Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee ArthroplastyActive, not recruitingPhase 2Suzhou Alphamab Co., Ltd.NCT06180889Written as Enoxaparin
- A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult ParticipantsCompletedPhase 2Regeneron PharmaceuticalsNCT05618808Written as Enoxaparin
Showing 20 of 92.
What changed recently
From the registry's own updates since Oct 15, 2026.
Newly registered1
- Effect of LMWH on Neonatal Outcomes in Isolated OligohydramniosOct 30, 2026NCT07907731
Codes
What other systems call Enoxaparin · ClinicalTrials.gg INT008623
- MeSH (NLM) D017984EnoxaparinOne source ClinicalTrials.gov
- UNII (FDA) E47C0NF7LVENOXAPARINConfirmed FDA, Wikidata
- RxNorm 67108Confirmed FDA, Wikidata
- Wikidata Q105969996enoxaparinConfirmed FDA, Wikidata
- NCI Thesaurus C1452EnoxaparinConfirmed FDA, Wikidata
- DrugBank DB01225One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017984 | Enoxaparin | One source ClinicalTrials.gov |
| UNII (FDA) | E47C0NF7LV | ENOXAPARIN | Confirmed FDA, Wikidata |
| RxNorm | 67108 | — | Confirmed FDA, Wikidata |
| Wikidata | Q105969996 | enoxaparin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C1452 | Enoxaparin | Confirmed FDA, Wikidata |
| DrugBank | DB01225 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.